Obesity: What’s Old, What’s New and How We Manage It: An Integrated Approach in Pharmacy Practice
- Referencias
- Cómo citar
- Del mismo autor
- Métricas
1. Yumuk V, Tsigos C, Fried M, Schindler K, Busetto L, Micic D, Toplak H; Obesity Management Task Force of the European Association for the Study of Obesity. European Guidelines for Obesity Management in Adults. Obes Facts. 2015;8(6):402-24.
2. Ioannides-Demos LL, Piccenna L, McNeil JJ. Pharmacotherapies for obesity: past, current, and future therapies. J Obes. 2011;2011:179674.
3. González Jiménez E. Obesity: Etiologic and pathophysiological analysis. Endocrinología y Nutrición (English Edition). 2013;60(1).
4. Clarke W, Dasgupta A. Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions, and Pharmacogenomics. Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions, and Pharmacogenomics. 2016.
5. Lorico S, Colton B. Medication management and pharmacokinetic changes after bariatric surgery. Vol. 66, Canadian Family Physician. 2020.
6. Son JW, Kim S. Comprehensive review of current and upcoming anti-obesity drugs. Diabetes and Metabolism Journal. 2020; 44.
7. Kosmalski M, Deska K, Bąk B, Różycka-Kosmalska M, Pietras T. Pharmacological Support for the Treatment of Obesity—Present and Future. Vol. 11, Healthcare (Switzerland). 2023.
2. Ioannides-Demos LL, Piccenna L, McNeil JJ. Pharmacotherapies for obesity: past, current, and future therapies. J Obes. 2011;2011:179674.
3. González Jiménez E. Obesity: Etiologic and pathophysiological analysis. Endocrinología y Nutrición (English Edition). 2013;60(1).
4. Clarke W, Dasgupta A. Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions, and Pharmacogenomics. Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions, and Pharmacogenomics. 2016.
5. Lorico S, Colton B. Medication management and pharmacokinetic changes after bariatric surgery. Vol. 66, Canadian Family Physician. 2020.
6. Son JW, Kim S. Comprehensive review of current and upcoming anti-obesity drugs. Diabetes and Metabolism Journal. 2020; 44.
7. Kosmalski M, Deska K, Bąk B, Różycka-Kosmalska M, Pietras T. Pharmacological Support for the Treatment of Obesity—Present and Future. Vol. 11, Healthcare (Switzerland). 2023.
Jesus, Ângelo. (2023). Obesity: What’s Old, What’s New and How We Manage It: An Integrated Approach in Pharmacy Practice. FarmaJournal, 8(2), 45–46. https://doi.org/10.14201/fj2023824546
Similar Articles
- Mihaela Metodieva, José Enrique Fuentes, Pharmaceutical Care in Obesity. Medicinal Plants in Obesity Treatment , FarmaJournal: Vol. 1 No. 2 (2016)
- Marta Araujo Valle , Lola Parra Astorgano, Analysis of interprofessional Communication Incidents Affecting Pharmaceutical Care in a Socio-Health Center Located in Castilla y Leon , FarmaJournal: Vol. 10 No. 1 (2025)
- Crisanto Martín, Laura Zoe Granados, Pharmaceutical Care and Study of Adherence to Treatment in patients with MDS at a Pharmacy in Plasencia from February to July, 2021 , FarmaJournal: Vol. 7 No. 1 (2022)
- Pedro Gómez, María Asunción González, Aníbal Martín, Juan José Ortiz De Urbina, “Efficacy and safety of eltrombopag as thromboyetic agent in the treatment of immune thrombocytopenic purpura in patients that started treatment at Complejo Asistencial Universitario de León during the period 2012-2015 , FarmaJournal: Vol. 2 No. 2 (2017)
- Antonio Sanz Diaz, Leticia Gómez De Segura Iriarte, EFECTIVENESS, SAFETY AND ACCEPTABILITY OF TERIFLUNOMIDE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS WHO STARTED TREATMENT AT HOSPITAL UNIVERISTARIO CENTRAL DE ASTURIAS (OVIEDO) IN 2015. , FarmaJournal: Vol. 2 No. 2 (2017)
- Eva Fernández Rodríguez, Tomás Codesal Gervás, Pharmaceutical care in flu and cold in a community pharmacy of Zamora capital in the months of September to February , FarmaJournal: Vol. 3 No. 2 (2018)
- Estefanía Garcia, José Enrique Fuentes, Adherence and Treatment Compliance in Osteoporosis , FarmaJournal: Vol. 1 No. 2 (2016)
- Ana María Olleros Anaya, Crisanto Martín Martín, Microbial communities in simbiosis with the human being. Benefits in therapeutics of minor pathologies. Béjar. Supervised practices February – July 2017. , FarmaJournal: Vol. 3 No. 2 (2018)
- Ana Belén Maestre Hernández, María Gonzalez Valdivieso, Josep Arasa, Elsa López Pintor, Study Review of the advantages and disadvantages of Dose Administration Aids (DDA) and evaluation of their adequacy to the patient's profile and type of pharmacy , FarmaJournal: Vol. 5 No. 1 (2020)
- Sergio A. Castrillejo, Julio López Abán, Claudio J. Salomon, Marta Pastor Navarro, José Luis Pedraz, Antonio Muro, Evaluation of new formulations of antihelmintic drugs for the treatment of schistosomiasis , FarmaJournal: Vol. 2 No. 2 (2017)
You may also start an advanced similarity search for this article.
Downloads
Download data is not yet available.
+
−